Page last updated: 2024-10-27

fluconazole and Peritoneal Carcinomatosis

fluconazole has been researched along with Peritoneal Carcinomatosis in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Coccidioidomycosis is the second most common endemic fungal infection in the southwestern United States."1.33Abdominal/pelvic Coccidioidomycosis. ( Brown, JV; Goldstein, BH; Micha, JP; Rettenmaier, MA; Robinson, PA, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Micha, JP1
Goldstein, BH1
Robinson, PA1
Rettenmaier, MA1
Brown, JV1

Other Studies

1 other study available for fluconazole and Peritoneal Carcinomatosis

ArticleYear
Abdominal/pelvic Coccidioidomycosis.
    Gynecologic oncology, 2005, Volume: 96, Issue:1

    Topics: Antifungal Agents; CA-125 Antigen; Coccidioidomycosis; Female; Fluconazole; Humans; Hysterectomy; Mi

2005